If you go to their website, the platforms listed are their LEAD drugs, not all of them.
"Our portfolio of lead drug candidates (in various stages of discovery optimization, and preclinical and clinical development) include"
MCT-275, MCT-175 and so on.
Clarifying, MCT-275, MCT-175 and so on are not listed. Does not make them non existent. I am not saying the article is or is not base on MCT-275 platform or base. What I am saying is that they have close sounding platforms for many items coming up.
I would be willing to bet this articule is about MCET and they are in a joint venture with someone. MCET likes to be very quiet about things until they decide to announce it and explode their stock into pennies. For crying out loud it has the same wording from the past. It has to be them and IMO this is going to the moon